The trademark PREDNIZOL was filed by Millpledge Limited, a corporation established under the laws of the United Kingdom of Great Britain and Northern Ireland (the "Applicant"). The application was published for oppositions on June 13, 2019, and received one opposition filed on September 10, 2019 by Dermapharm AG on Likelihood of confusion. the opponent was represented by DR. KUNZ-HALLSTEIN RECHTSANWÄLTE and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued September 10, 2019
The application was filed in English, and English was also language of all opposition proceedings (Italian was selected as the second language).
Appointment and Replacement of representative of the trademark registration was recorded on January 7, 2021.